Alteri Wealth LLC Acquires New Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Alteri Wealth LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 1,433 shares of the company's stock, valued at approximately $430,000.

Several other hedge funds also recently modified their holdings of the business. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare in the fourth quarter worth about $31,000. Tidemark LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $36,000. Activest Wealth Management raised its stake in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after buying an additional 125 shares during the period. Pinnacle Bancorp Inc. increased its stake in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after purchasing an additional 50 shares during the period. Finally, Legacy Investment Solutions LLC grew its position in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after buying an additional 95 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Trading Up 1.4 %

Shares of HCA stock traded up $4.88 during trading hours on Wednesday, hitting $361.58. 1,984,379 shares of the company were exchanged, compared to its average volume of 1,404,250. The firm has a market cap of $86.99 billion, a PE ratio of 16.46, a PEG ratio of 1.10 and a beta of 1.46. The firm has a fifty day moving average of $333.12 and a 200 day moving average of $329.41. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same quarter last year, the firm posted $5.36 earnings per share. The business's quarterly revenue was up 5.7% on a year-over-year basis. Analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date is Monday, June 16th. HCA Healthcare's payout ratio is 12.81%.

Analyst Upgrades and Downgrades

HCA has been the subject of several recent research reports. Barclays decreased their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research note on Monday, January 27th. Robert W. Baird restated a "neutral" rating and issued a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. StockNews.com upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Bank of America decreased their target price on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Finally, Guggenheim initiated coverage on HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating on the stock. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $381.13.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.